An FDA panel spread misinformation about SSRI use in pregnancy, alarming doctors

A panel organized by the FDA cast doubts on the safety of antidepressants during pregnancy drawing ire from doctors who say SSRIs are a crucial medication option for women with perinatal depression Image credit Mykola Sosiukin